ENDOSENSE
Endosense is a medical technology company focused on improving the efficacy, safety and reproducibility of catheter ablation for the treatment of cardiac arrhythmias. Granted the CE mark in May 2009, Endosense's TactiCath® is the first and only force-sensing ablation catheter to give physicians a real-time, objective measure of contact force during the catheter ablation procedure. It has undergone considerable pre-clinical and clinical testing, the results of which have created a solid foundation of evidence supporting the feasibility, safety and value of contact force sensing during catheter ablation.
ENDOSENSE
Industry:
Biotechnology Health Care Medical Device Therapeutics
Founded:
2003-01-01
Address:
Geneva, Geneve, Switzerland
Country:
Switzerland
Website Url:
http://www.endosense.com
Total Employee:
51+
Status:
Active
Contact:
41 22 306 19 60
Total Funding:
141.54 M USD
Technology used in webpage:
IPv6 Cloudflare Hosting Cloudflare DNS
Similar Organizations
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Passage Bio
Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.
Current Advisors List
Board_member
Board_member
Board_member
Board_member
Board_member
Board_member
2005-01-01
Founder
Investors List
Andera Partners
Andera Partners investment in Series C - Endosense
Initiative Capital Romandie
Initiative Capital Romandie investment in Series C - Endosense
Ysios Capital
Ysios Capital investment in Series C - Endosense
Gimv
Gimv investment in Series C - Endosense
VI Partners
VI Partners investment in Series C - Endosense
Sectoral Asset Management
Sectoral Asset Management investment in Series C - Endosense
Neomed Management
Neomed Management investment in Series C - Endosense
NGN Capital
NGN Capital investment in Series C - Endosense
VI Partners
VI Partners investment in Series C - Endosense
Initiative Capital
Initiative Capital investment in Series C - Endosense
Official Site Inspections
http://www.endosense.com
- Host name: viridian01.parklogic.com
- IP address: 172.233.219.49
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Endosense"
Endosense Company Profile 2024: Valuation, Investors …
Endosense General Information Description. Developer of medical technology designed for contact-force measurement in catheter ablation. The company offers force-sensing ablation catheters, thereby helping physicians with a real-time, …See details»
Endosense - LinkedIn
Endosense | 1,504 followers on LinkedIn. Endosense is a medical technology company focused on improving the efficacy, safety and reproducibility of catheter ablation for the treatment of …See details»
Endosense SA - Meyrin, Switzerland - bionity.com
May 12, 2010 Endosense’s flagship product is the TactiCath, the first force-sensing ablation catheter to give physicians a real-time, objective measure of contact force during the catheter …See details»
Endosense - Products, Competitors, Financials, Employees, …
Endosense is a medical technology company focused on improving the efficacy, safety and accessibility of catheter ablation for the treatment of cardiac arrhythmias. The company …See details»
Endosense - Overview, News & Similar companies | ZoomInfo.com
Endosense contact info: Phone number: +41 223061960 Website: www.endosense.com What does Endosense do? Founded in Geneva in 2003, Endosense is a medical technology …See details»
ENDOSENSE SA - Drug pipelines, Patents, Clinical trials - Synapse
Explore ENDOSENSE SA with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, 2 news.See details»
Endosense - VentureRadar
Founded in Geneva in 2003, Endosense is a medical technology company focused on improving the efficacy, safety and accessibility of catheter ablation for the treatment of cardiac …See details»
Endosense - Crustdata Company Profile, Funding and Growth
Endosense is a medical technology company focused on improving the efficacy, safety and reproducibility of catheter ablation for the treatment of cardiac arrhythmias. Granted the CE …See details»
Endosense - Funding, Financials, Valuation & Investors - Crunchbase
Endosense is a medical tech company focused on improving the reproducibility of catheter ablation for the treatment of cardiac arrhythmias. ... How much funding has this organization …See details»
Endosense: Contact Details and Business Profile - RocketReach
Endosense is a medical technology company focused on improving the efficacy, safety and reproducibility of catheter ablation for the treatment of cardiac arrhythmias. The company has …See details»
Endosense - Crunchbase
Endosense is a medical tech company focused on improving the reproducibility of catheter ablation for the treatment of cardiac arrhythmias. Search Crunchbase. Start Free Trial . …See details»
Endosense - Company Profile - Tracxn
Nov 15, 2024 Endosense ranks 2nd among 5 active competitors. 1 of its competitors is funded while 3 have exited. Overall, Endosense and its competitors have raised over $112M in …See details»
St. Jude Medical acquires Endosense for up to CHF309 million
Aug 19, 2013 St. Jude Medical has made an initial payment of approximately 159 million Swiss francs ($170 million USD) and acquired 100 percent of the outstanding equity of …See details»
Endosense - Updates, News, Events, Signals & Triggers - Crunchbase
Endosense is a medical tech company focused on improving the reproducibility of catheter ablation for the treatment of cardiac arrhythmias. Search Crunchbase. Start Free Trial . …See details»
St. Jude’s Latest Acquisition Gives it Competitive Edge in Crowded ...
Aug 23, 2013 St. Jude's acquisition of force-sensing ablation catheter firm Endosense may help it to get a leg up on competition.See details»
Endosense Closes $40.3M Series C - venturecapitaljournal.com
Nov 27, 2012 Endosense, a developer of technology for catheter ablation for the treatment of cardiac arrhythmias, has raised $40.3 million in Series C financing. new investor NGN Capital …See details»
Endosense - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Endosense uses 8 technology products and services including HTML5, Google Doubleclick, and F5 NGINX, according to G2 Stack. Endosense is actively using 19 technologies for its website, …See details»
Endosense - Contacts, Employees, Board Members, Advisors
Organization. Endosense . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Number of Board Member and Advisor …See details»
St.Jude’s Endosense Acquisition Makes Sense - medlatest.com
Aug 19, 2013 St.Jude says the acquisition of Endosense is highly complementary to its business, providing a strong, patent-protected platform for future product development. …See details»